Vapreotide API is a synthetic cyclic octapeptide and somatostatin analogue identified by CAS No. 103222-11-3. It has the molecular formula C57H70N12O9S2 and a molecular weight of approximately 1131.4 g/mol. Vapreotide is also known as RC-160 and is classified as a specialized peptide compound.
Vapreotide has a structurally defined cyclic peptide sequence and contains a characteristic disulfide linkage. Its chemical and structural properties make it relevant to pharmaceutical research, peptide development and specialized API applications.
Vapreotide consists of an eight-amino-acid peptide sequence:
D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH₂
The corresponding one-letter sequence is FCYWKVCW. The molecule contains a Cys2–Cys7 disulfide bridge, which produces its characteristic cyclic peptide structure.
Important chemical characteristics include:
These characteristics provide important reference points for the identification and analytical characterization of Vapreotide API.
Vapreotide belongs to the specialized category of peptide APIs. Unlike many conventional small-molecule APIs, peptide compounds have complex structures that require appropriate analytical techniques to confirm identity, purity and structural integrity.
For Vapreotide API, analytical evaluation may include:
Because Vapreotide is a cyclic peptide, maintaining the correct peptide sequence and disulfide connectivity is an important aspect of quality evaluation.
Vapreotide has been investigated as a somatostatin analogue and has been studied in pharmaceutical and biomedical research. PubChem classifies Vapreotide under somatostatin and analogue-related pharmacology and reports research involving conditions including esophageal variceal bleeding and AIDS-related diarrhea.
Potential research and pharmaceutical application areas include:
Vapreotide has also been investigated for its effects on somatostatin-related biological pathways, including inhibition of growth hormone release and effects on splanchnic blood flow.
The defined cyclic structure of Vapreotide makes it an important material for research involving peptide pharmacology and pharmaceutical development.
Researchers working with Vapreotide may focus on:
Its relatively complex molecular structure means that suitable analytical controls are important when developing or evaluating Vapreotide-containing pharmaceutical materials.
Vapreotide API should be evaluated using an appropriate quality specification established for the specific material and manufacturing process.
Important quality parameters can include:
For Vapreotide, it is important not to treat a single supplier's COA result as a universal pharmacopeial specification. Different manufacturers may establish different validated specifications depending on manufacturing process, intended use and regulatory requirements.
A reliable Vapreotide API manufacturer and supplier in India should provide appropriate documentation for the supplied material, including product identity, purity information and relevant batch analytical data.
When sourcing Vapreotide, customers should verify:
For pharmaceutical development and research applications, the exact chemical form of the product should also be confirmed before procurement.
Vapreotide offers several characteristics relevant to specialized peptide research:
These characteristics make Vapreotide a specialized material within the peptide API category.
Peptide APIs require controlled storage and handling conditions to maintain material quality. Vapreotide should be stored according to the specific manufacturer's recommendations and Certificate of Analysis.
Important considerations include:
Specific storage requirements should always be confirmed from the product documentation supplied with the individual batch.
Vapreotide is a specialized pharmaceutical peptide API with applications in research involving somatostatin analogues and peptide pharmacology. Its defined molecular structure, cyclic configuration and disulfide linkage make appropriate analytical characterization essential.
Companies searching for Vapreotide API manufacturer in India, Vapreotide API supplier in India, or Vapreotide peptide API supplier can evaluate the product based on its chemical identity, analytical profile, batch documentation and intended application.
Vapreotide is therefore relevant to pharmaceutical companies, research organizations and formulation developers working with specialty peptide compounds and somatostatin-related research.
Product Name: Vapreotide
CAS No.: 103222-11-3
Molecular Formula: C57H70N12O9S2
Molecular Weight: 1131.4 g/mol
Peptide Sequence: D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH₂
Short Sequence: FCYWKVCW
Disulfide Bridge: Cys2–Cys7
Product Category: Peptide API / Somatostatin Analogue
Development Code: RC-160
Vapreotide's chemical identity and molecular characteristics are documented in PubChem and FDA-linked substance records.
Vapreotide API is a specialized synthetic cyclic octapeptide and somatostatin analogue with CAS No. 103222-11-3, molecular formula C57H70N12O9S2 and molecular weight 1131.4 g/mol. Its defined peptide sequence and Cys2–Cys7 disulfide bridge are important characteristics for pharmaceutical and analytical research.
With applications in peptide API research, somatostatin analogue studies, pharmaceutical formulation development, receptor pharmacology and drug-delivery research, Vapreotide is an important specialty peptide material for pharmaceutical and biotechnology applications.
For organizations seeking a Vapreotide API manufacturer and supplier in India, appropriate product specifications, analytical documentation and batch-specific quality information should be reviewed to ensure suitability for the intended pharmaceutical or research application.
| Parameter | Specification |
|---|---|
| Appearance | white to off-white crystalline powder |